"Our 3 board-certified doctors provide compassionate retinal care, medical and surgical, at 3 locations in Southern Oregon, Ashland, Medford, and Grants Pass."

During the past decade, Retina & Vitreous Center of Southern Oregon conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Retina & Vitreous Center of Southern Oregon" are "Geographic Atrophy" (2 trials). Many other conditions were trialed in "Retina & Vitreous Center of Southern Oregon" in a lesser frequency.

Most popular intervention types in "Retina & Vitreous Center of Southern Oregon" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lampalizumab" (2 trials) and "Sham Comparator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Retina & Vitreous Center of Southern Oregon" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Retina & Vitreous Center of Southern Oregon". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Retina & Vitreous Center of Southern Oregon, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Retina & Vitreous Center of Southern Oregon, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".